Tate & Lyle PLC

TATE: XLON (GBR)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|c#LOCK|^S^wVLOCK|VWf<@G

Tate & Lyle Earnings: Cost Synergies Ahead of Plan, Shares Rebound Mid-Single-Digits but Remain Cheap

Tate & Lyle reported a 3% revenue decline and a 6% EBITDA decline on a constant-currency and pro forma basis, in line with expectations following its October preclose statement. Shares rose 5% on Nov. 6 as investors welcomed faster-than-expected cost synergy realization.

Sponsor Center